PSMA is overexpressed in 90% of metastatic PCa cases, with levels up to 1,000 times higher than in benign tissues, correlating strongly with tumor aggressiveness and Gleason scores (18, 19). Here, FOLH1 is linked to posterior cortical atrophy.